🔎 Trials Near Me

Home › Glioblastoma › NCT06989086

FearLess in NeuroOncology

Recruiting

FearLess in Neuro-Oncology

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

Patients:

* Self-report a diagnosis of a primary malignant brain tumor (grade II-IV)
* \>2 weeks post-cranial resection or biopsy
* Elevated Fear of Recurrence Distress Rating
* Primarily English speaking
* \>/= 18 years of age at the time of enrollment

Caregivers:

* nonprofessional caregiver to a patient with a primary malignant brain tumor (grade II-IV)
* Elevated Fear of Recurrence Distress Rating
* Primarily English speaking
* \>/= 18 years of age at the time of enrollment

Exclusion Criteria:

Patient / Caregiver Exclusion:

* Cognitive impairment that might prohibit active intervention engagement
* Inability to understand and provide informed consent
* Inability to attend virtual sessions due to unstable or no internet connection

About the study

The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers

What is being tested

Sponsor: Virginia Commonwealth University · Participants: 112 · Started: Jun 24, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06989086

Locations in the U.S.

VirginiaVirginia Commonwealth University, Richmond

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.